Jesenice, Slovenia

Sebastjan Reven

This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2011-2017.


% Patents Active = 66.7

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Jesenice, SI (2011)
  • Jecenice, SI (2014 - 2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sebastjan Reven

Introduction

Sebastjan Reven is a notable inventor based in Jecenice, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of stable drug compositions. With a total of 3 patents to his name, his work has garnered attention for its innovative approach to medication stability.

Latest Patents

Reven's latest patents include a pharmaceutical composition that features a stable formulation of telmisartan and hydrochlorothiazide. This formulation is unique as it maintains both substances in separate units, exhibiting exceptional stability even under stress conditions. This innovation is crucial for ensuring the efficacy and safety of the medication.

Career Highlights

Sebastjan Reven is currently employed at Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. His role at Lek has allowed him to focus on developing advanced pharmaceutical formulations that address critical health needs. His expertise in this area has positioned him as a valuable asset to the company.

Collaborations

Throughout his career, Reven has collaborated with several talented individuals, including Igor Legen and Adnan Beso. These collaborations have fostered a creative environment that encourages the development of innovative solutions in the pharmaceutical industry.

Conclusion

Sebastjan Reven's contributions to pharmaceutical innovation highlight the importance of stability in drug formulations. His work not only advances the field but also improves patient outcomes through enhanced medication reliability.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…